LAUSANNE, Switzerland--(BUSINESS WIRE)--Galderma today announced top-line results from a Phase 2 study on the impact of dose escalation on the duration of effect and the efficacy and safety of a ...
The Medicines and Healthcare products Regulatory Agency has given market authorisation to Ipsen and Gladerma’s new wrinkle therapy Azzalure, which works by relaxing the muscles around the eyes. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results